Literature DB >> 8523334

Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis.

M Nagashima1, S Yoshino, T Ishiwata, G Asano.   

Abstract

OBJECTIVE: To examine the localization and role of vascular endothelial growth factor (VEGF), an endothelial cell specific mitogen, in rheumatoid arthritis (RA).
METHODS: Immunohistochemical staining, reverse transcription polymerase chain reaction (RT-PCR) analysis and in situ hybridization for VEGF were performed on synovial tissues from 10 patients with RA, 5 patients with osteoarthritis (OA) and 3 autopsy cases.
RESULTS: In RA, the proliferative ratio of synovial lining cells and vascular endothelial cells was significantly higher than that in OA and normal synovial tissues. Immunohistochemical staining demonstrated that VEGF polypeptide was strongly expressed in subsynovial macrophages, fibroblasts surrounding microvessels, vascular smooth muscle cells, and synovial lining cells, but not in vascular endothelial cells of patients with RA. On the other hand, in patients with OA and normal cases, VEGF polypeptide was slightly expressed in synovial lining cells and fibroblasts. RT-PCR showed a positive reaction for VEGF messenger RNA in RA, OA, and normal synovial tissues. A large number of subsynovial macrophages, fibroblasts, vascular smooth muscle cells, and synovial lining cells from patients with RA expressed VEGF mRNA using in situ hybridization.
CONCLUSION: In RA, VEGF is synthesized and released by a large number of subsynovial macrophages, fibroblasts surrounding microvessels, vascular smooth muscle cells, and synovial lining cells and may stimulate endothelial proliferation in a paracrine manner via VEGF receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8523334

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  43 in total

Review 1.  The role of angiogenesis in rheumatoid arthritis: recent developments.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 3.  Adhesion molecules in rheumatoid arthritis.

Authors:  N Oppenheimer-Marks; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  1998

4.  The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.

Authors:  Takuma Kusabe; Yuko Waguri-Nagaya; Tomohiro Tanikawa; Mineyoshi Aoyama; Muneyoshi Fukuoka; Masaaki Kobayashi; Takanobu Otsuka; Kiyofumi Asai
Journal:  Rheumatol Int       Date:  2005-07-01       Impact factor: 2.631

5.  Anti-TNF-alpha antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor levels in patients with rheumatoid arthritis: a pilot study.

Authors:  Johannes Strunk; Elisabeth Bundke; Uwe Lange
Journal:  Rheumatol Int       Date:  2005-07-06       Impact factor: 2.631

Review 6.  Cytokines as biochemical markers for knee osteoarthritis.

Authors:  Thomas Mabey; Sittisak Honsawek
Journal:  World J Orthop       Date:  2015-01-18

7.  Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway.

Authors:  M Xiong; G Elson; D Legarda; S J Leibovich
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Expression of vascular endothelial growth factor and angiogenesis in patellar tendon grafts in the early phase after anterior cruciate ligament reconstruction.

Authors:  T Yoshikawa; H Tohyama; H Enomoto; H Matsumoto; Y Toyama; K Yasuda
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2006-03-14       Impact factor: 4.342

9.  Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy.

Authors:  Norihiro Nishimoto; Nobuyuki Miyasaka; Kazuhiko Yamamoto; Shinichi Kawai; Tsutomu Takeuchi; Junichi Azuma; Tadamitsu Kishimoto
Journal:  Mod Rheumatol       Date:  2008-11-01       Impact factor: 3.023

10.  Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy.

Authors:  Elena Izquierdo; Juan D Cañete; Raquel Celis; Begoña Santiago; Alicia Usategui; Raimon Sanmartí; Manuel J Del Rey; José L Pablos
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.